PX’THERAPEUTICS and ADVAXIS to collaborate for the process development of Lm based immunotherapies

,
Grenoble (France), January 17th, 2018 - PX’Therapeutics, a CDMO (Contract Development and Manufacturing Organization) has signed an agreement with Advaxis, Inc., a US-based, clinical stage biotechnology company, to support it in the process…